JOIN THE FIGHT AGAINST ALZHEIMER’S DISEASE-THE NERAMEXANE STUDY
Tuesday, March 13th, 2007Alzheimer’s disease Clinical research Trial
by Risa Levovsky
Caregiver-Journalist-Advocate for successful Aging
www.alzheimers-tips.com
Do you know someone who has moderate to severe Alzheimer’s disease?
If so, now is the time to consider participation in a clinical trial
that may play an important role in providing a better treatment
option.
What information can you provide about the Neramexane Study?
Neramexane is an investigational drug in development in the United
States by Forest Laboratories for the treatment of moderate to
severe Alzheimer’s disease. This study will investigate whether
Neramexane can lessen the impact of Alzheimer’s disease and improve
patients’ abilities to understand and retain information and perform
daily tasks.
(more…)